A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation

Condition:   Irritable Bowel Syndrome Characterized by Constipation Interventions:   Drug: Linaclotide;   Drug: Placebo Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials